Delivery Order SPE2DB20D3101-SPE2DB25FRTM7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease treatment. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.01 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $25,630.25 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $6,768.87 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (60-unit package), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which closes on August 19, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,545.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $27,169.72 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $8,093.82 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTM7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,445.83 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication delivered in a 60-dose inhaler. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement executed under a competitive, non-set-aside process. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and primary distribution center for federal medical supply operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC capacity enables the fulfillment of numerous delivery orders across therapeutic domains, supporting the Department of Defense's critical medical supply requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/25/25 |